Viridian Therapeutics(VRDN)
$30.48-0.77 (-2.46%)
VRDN
Viridian Therapeutics Revenue
$30.48
At close:-0.77 (-2.46%)
Want to see VRDN full AI Analyst Report?
Viridian Therapeutics (VRDN) Revenue
1,572 Followers
Viridian Therapeutics Revenue
Viridian Therapeutics had a revenue of 25.75M in the quarter ending Sep 30, 2026, with 8967.61%. This bring the company's revenue in the last twelve months to 26.31M, Decreased 63.01%. In the fiscal year ending Dec 31, 2025, Viridian Therapeutics had annual revenue of 70.85M with 23359.93% growth.
- Revenue (ttm)
- 26.31M
- Revenue Growth
- -62.83%
- P/S Ratio
- 50.09
- Revenue/Employee
- $281,147
- Employees
- 252
- Market Cap
- $3.55B
Revenue Chart
Viridian Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.85M | 70.55M | 23359.93% |
| Dec 31, 2024 | 302.00K | -12.00K | -3.82% |
| Dec 31, 2023 | 314.00K | -1.46M | -82.28% |
| Dec 31, 2022 | 1.77M | -1.19M | -40.20% |
| Dec 31, 2021 | 2.96M | 1.91M | 182.19% |
| Dec 31, 2020 | 1.05M | -3.41M | -76.46% |
| Dec 31, 2019 | 4.46M | -3.92M | -46.80% |
| Dec 31, 2018 | 8.39M | 4.38M | 109.49% |
| Dec 31, 2017 | 4.00M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.